Trigger Point Electroacupuncture Treatment in Patients with Chronic Low Back Pain
Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Mar 5, 2025
Trial Information
Current as of August 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new treatment for people suffering from chronic low back pain (CLBP) that focuses on a method called Trigger Point electroacupuncture. This technique combines traditional acupuncture with electrical stimulation to help relieve pain faster. Previous research suggests that targeting specific painful spots, known as trigger points, may provide better pain relief than regular acupuncture for those with CLBP. However, this study aims to compare the effectiveness of Trigger Point electroacupuncture against regular electroacupuncture to see which method works better for pain relief.
To participate in this trial, individuals must be at least 20 years old and have been experiencing low back pain for more than three months, with a pain level of at least 5 out of 10. Participants should also have trigger points in their back. However, those with certain serious health conditions or who are receiving other treatments for their pain will not be eligible. If you decide to join the study, you can expect to receive treatment focused on your specific pain areas, and researchers will monitor your progress throughout the trial. This study is not currently recruiting participants, but it aims to provide valuable information that could lead to better treatment options for chronic low back pain in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 20 or older who consented to participate in the study;
- • Individuals experiencing LBP persisting for more than 3 months with an average VAS score of 5 cm or over;
- • Patients displaying trigger points in back
- Exclusion Criteria:
- • Major trauma or systemic disease such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, Scheuermann disease;
- • Systemic symptoms such as weight loss, fever of unknown origin, anorexia, personal history of malignancy, diffuse pain and joint stiffness;
- • Symptoms of infection such as fever, meningeal irritation signs, photophobia;
- • Symptoms of central motor neuron damage such as Hoffmann sign, Babinski sign, hyperreflexia, spasticity, incontinence, sexual dysfunction;
- • Symptoms of serious acute diseases such as myocardial infarction (chest pain, sweating, shortness of breath), arterial dissections (tearing sensation, headache, blurred vision);
- • Conditions unsuitable for acupuncture such as inflammation of skin in need of acupuncture, weak or exhausted patients, severe comorbidities;
- • Being treated with other methods. Elimination criteria: Patients experiencing adverse events from the intervention leading to their discomfort and withdrawal from the study
About University Of Medicine And Pharmacy At Ho Chi Minh City
The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh, , Vietnam
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported